DK1397366T3 - Hidtil ukendt ligander for nicotinacetylcholinreceptorer egnede i terapi - Google Patents

Hidtil ukendt ligander for nicotinacetylcholinreceptorer egnede i terapi

Info

Publication number: DK1397366T3
Authority: DK; Denmark
Prior art keywords: therapy; nicotinic acetylcholine; acetylcholine receptors; novel ligands; receptors suitable
Prior art date: 2001-06-01

Application number

DK02731063T

Other languages

English (en)

Inventor

Eifion Phillips

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-06-01

Filing date

2002-05-29

Publication date

2007-05-07

2002-05-29 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2007-05-07 Application granted granted Critical

2007-05-07 Publication of DK1397366T3 publication Critical patent/DK1397366T3/da

Links

238000002560 therapeutic procedure Methods 0.000 title abstract 2
102000019315 Nicotinic acetylcholine receptors Human genes 0.000 title 1
108050006807 Nicotinic acetylcholine receptors Proteins 0.000 title 1
239000003446 ligand Substances 0.000 title 1
150000001875 compounds Chemical class 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Toxicology (AREA)
Psychology (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Anesthesiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

DK02731063T 2001-06-01 2002-05-29 Hidtil ukendt ligander for nicotinacetylcholinreceptorer egnede i terapi DK1397366T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US29520601P	2001-06-01	2001-06-01
PCT/SE2002/001031 WO2002096912A1 (en)	2001-06-01	2002-05-29	Novel ligand for nicotinic acetylcholine receptors useful in therapy

Publications (1)

Publication Number	Publication Date
DK1397366T3 true DK1397366T3 (da)	2007-05-07

Family

ID=23136711

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK02731063T DK1397366T3 (da)	2001-06-01	2002-05-29	Hidtil ukendt ligander for nicotinacetylcholinreceptorer egnede i terapi

Country Status (18)

Country	Link
EP (1)	EP1397366B1 (da)
JP (1)	JP2004532877A (da)
KR (1)	KR20040003021A (da)
CN (1)	CN1294136C (da)
AT (1)	ATE353332T1 (da)
BR (1)	BR0210075A (da)
CA (1)	CA2455341A1 (da)
DE (1)	DE60218032T2 (da)
DK (1)	DK1397366T3 (da)
ES (1)	ES2280538T3 (da)
IL (1)	IL158735A0 (da)
MX (1)	MXPA03010996A (da)
NO (1)	NO20035333D0 (da)
NZ (1)	NZ529426A (da)
PT (1)	PT1397366E (da)
SI (1)	SI1397366T1 (da)
WO (1)	WO2002096912A1 (da)
ZA (1)	ZA200308779B (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10164139A1 (de)	2001-12-27	2003-07-10	Bayer Ag	2-Heteroarylcarbonsäureamide
US7417049B2 (en) *	2002-04-18	2008-08-26	Astrazeneca Ab	Furyl compounds
NZ561993A (en) *	2002-04-18	2008-09-26	Astrazeneca Ab	Spiroazabicyclic heterocyclic amines as potent ligands for nicotinic acetylcholine receptors
ES2348282T3 (es) *	2002-04-18	2010-12-02	Astrazeneca Ab	Compuestos de tienilo.
BRPI0415546A (pt)	2003-10-21	2006-12-26	Astrazeneca Ab	composto, composição farmacêutica, uso de um composto, e, métodos de tratamento ou profilaxia de doenças ou condições humanas, e de distúrbios
TW200813067A (en)	2006-05-17	2008-03-16	Astrazeneca Ab	Nicotinic acetylcholine receptor ligands
SA08290475B1 (ar)	2007-08-02	2013-06-22	Targacept Inc	(2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه
CN102131791B (zh)	2008-06-20	2014-12-24	阿斯利康(瑞典)有限公司	二苯并硫杂氮杂*衍生物及其用途
TW201031664A (en)	2009-01-26	2010-09-01	Targacept Inc	Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide
PE20170923A1 (es)	2010-05-17	2017-07-12	Forum Pharmaceuticals Inc	Una forma cristalina de clorhidrato de (r)-7-cloro-n-(quinuclidin-3-il)benzo[b]tiofeno-2-carboxamida monohidratado
GB201111705D0 (en)	2011-07-07	2011-08-24	Takeda Pharmaceutical	Compounds and their use
GB201111704D0 (en)	2011-07-07	2011-08-24	Takeda Pharmaceutical	Novel compounds
JO3115B1 (ar)	2011-08-22	2017-09-20	Takeda Pharmaceuticals Co	مركبات بيريدازينون واستخدامها كمثبطات daao
EP3461481A1 (en)	2012-05-08	2019-04-03	Forum Pharmaceuticals Inc.	Methods of maintaining, treating or improving cognitive function
GB201209587D0 (en)	2012-05-30	2012-07-11	Takeda Pharmaceutical	Therapeutic compounds
JP6478923B2 (ja)	2013-02-07	2019-03-06	ヘプタレスセラピューティクスリミテッドＨｅｐｔａｒｅｓＴｈｅｒａｐｅｕｔｉｃｓＬｉｍｉｔｅｄ	ムスカリンｍ４受容体アゴニストとしてのピペリジン−１−イル及びアゼピン−１−イルカルボキシレート
WO2014202999A1 (en)	2013-06-21	2014-12-24	Takeda Cambridge Limited	1-sulfonyl piperidine derivatives as modulators of prokineticin receptors
GB201314286D0 (en)	2013-08-08	2013-09-25	Takeda Pharmaceutical	Therapeutic Compounds
GB201318222D0 (en)	2013-10-15	2013-11-27	Takeda Pharmaceutical	Novel compounds
GB201320905D0 (en)	2013-11-27	2014-01-08	Takeda Pharmaceutical	Therapeutic compounds
TW201613864A (en)	2014-02-20	2016-04-16	Takeda Pharmaceutical	Novel compounds
GB201616839D0 (en)	2016-10-04	2016-11-16	Takeda Pharmaceutical Company Limited	Therapeutic compounds
GB201619514D0 (en)	2016-11-18	2017-01-04	Takeda Pharmaceuticals Co	Novel compounds
JP2021138648A (ja)	2020-03-04	2021-09-16	武田薬品工業株式会社	経口固形製剤
GB202414193D0 (en)	2024-09-27	2024-11-13	Addex Pharmaceuticals Sa	Novel compounds
GB202414197D0 (en)	2024-09-27	2024-11-13	Addex Pharmaceuticals Sa	Novel compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1998054189A1 (en) *	1997-05-30	1998-12-03	Neurosearch A/S	Spiro-quinuclidine derivatives, their preparation and use
AR013184A1 (es) *	1997-07-18	2000-12-13	Astrazeneca Ab	Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis
SE9900100D0 (sv) *	1999-01-15	1999-01-15	Astra Ab	New compounds

2002
- 2002-05-29 BR BR0210075-4A patent/BR0210075A/pt not_active IP Right Cessation
- 2002-05-29 DK DK02731063T patent/DK1397366T3/da active
- 2002-05-29 NZ NZ529426A patent/NZ529426A/en unknown
- 2002-05-29 ES ES02731063T patent/ES2280538T3/es not_active Expired - Lifetime
- 2002-05-29 KR KR10-2003-7015462A patent/KR20040003021A/ko not_active Ceased
- 2002-05-29 CN CNB028110498A patent/CN1294136C/zh not_active Expired - Fee Related
- 2002-05-29 WO PCT/SE2002/001031 patent/WO2002096912A1/en not_active Ceased
- 2002-05-29 EP EP02731063A patent/EP1397366B1/en not_active Expired - Lifetime
- 2002-05-29 SI SI200230510T patent/SI1397366T1/sl unknown
- 2002-05-29 MX MXPA03010996A patent/MXPA03010996A/es active IP Right Grant
- 2002-05-29 CA CA002455341A patent/CA2455341A1/en not_active Abandoned
- 2002-05-29 PT PT02731063T patent/PT1397366E/pt unknown
- 2002-05-29 IL IL15873502A patent/IL158735A0/xx unknown
- 2002-05-29 AT AT02731063T patent/ATE353332T1/de not_active IP Right Cessation
- 2002-05-29 DE DE60218032T patent/DE60218032T2/de not_active Expired - Fee Related
- 2002-05-29 JP JP2003500091A patent/JP2004532877A/ja active Pending
2003
- 2003-11-11 ZA ZA200308779A patent/ZA200308779B/en unknown
- 2003-11-28 NO NO20035333A patent/NO20035333D0/no unknown

Also Published As

Publication number	Publication date
EP1397366B1 (en)	2007-02-07
WO2002096912A1 (en)	2002-12-05
JP2004532877A (ja)	2004-10-28
MXPA03010996A (es)	2004-02-27
EP1397366A1 (en)	2004-03-17
BR0210075A (pt)	2004-08-17
ES2280538T3 (es)	2007-09-16
ATE353332T1 (de)	2007-02-15
HK1063787A1 (en)	2005-01-14
PT1397366E (pt)	2007-04-30
CA2455341A1 (en)	2002-12-05
SI1397366T1 (sl)	2007-06-30
IL158735A0 (en)	2004-05-12
CN1294136C (zh)	2007-01-10
CN1512995A (zh)	2004-07-14
NO20035333D0 (no)	2003-11-28
NZ529426A (en)	2005-07-29
DE60218032D1 (de)	2007-03-22
ZA200308779B (en)	2005-02-11
KR20040003021A (ko)	2004-01-07
DE60218032T2 (de)	2007-08-16

Publication	Publication Date	Title
DK1397366T3 (da)	2007-05-07	Hidtil ukendt ligander for nicotinacetylcholinreceptorer egnede i terapi
CY1113054T1 (el)	2016-04-13	Παραγωγα διαμινης
DE60325234D1 (de)	2009-01-22	Biaryldiazabicycloalkanamide als nicotinische acetylcholinagonisten
DE60334536D1 (de)	2010-11-25	Furylverbindungen
NO20044995L (no)	2005-01-18	Heterosykliske forbindelser
DE60112974D1 (en)	2005-09-29	Carbolinderivate
MXPA02011977A (es)	2003-04-22	Herbicidas de piridina sustituidas.
ATE477256T1 (de)	2010-08-15	Thienylverbindungen
DE60216233D1 (en)	2007-01-04	Carbolinderivate
SE0004245D0 (sv)	2000-11-20	Novel compounds and their use
AU2001266575A1 (en)	2002-01-08	Chemical compounds
ATE303384T1 (de)	2005-09-15	1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
ATE370952T1 (de)	2007-09-15	Neue verbindungen
MX2007006743A (es)	2007-07-09	Ligandos del receptor de acetilcolina nicotinica.
DE60112960D1 (de)	2005-09-29	Kondensierte pyridoindolderivate
NO20062629L (no)	2006-09-06	Oksazolderivater av tetrackliner
BRPI0512310A (pt)	2008-02-26	compostos quìmicos
MXPA02012472A (es)	2004-01-26	Compuestos quimicos.
TR200402546T4 (tr)	2004-12-21	Taksan türevleri hazırlamak için işlem.
BR0205223B1 (pt)	2011-05-17	máquina ferramenta portátil.
ATE284703T1 (de)	2005-01-15	Kristallmodifikation eines cyclischen depsipeptids mit besserer wirksamkeit
ATE276259T1 (de)	2004-10-15	Dihydroporphyrinderivate und ihre verwendung
ATE455779T1 (de)	2010-02-15	Bis-(n,n'-bis-(2-haloethyl)amino)-phosphoramida e als anti-tumormittel
MXPA03003478A (es)	2003-07-14	Compuestos heterociclicos 2-sustituidos y su uso para tratar resistencia a multiples farmacos.
DE60214397D1 (en)	2006-10-12	2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta(a)naphthalenyl derivate mit antipsychotischer aktivität